Skip to content

Book value per share at other companies

Cytokinetics logo
CytokineticsCYTK
-$6.71-198%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.19-1.7%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$7.98+27.6%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$4.34-42.5%
Scholar Rock logo
Scholar RockSRRK
$2.17-22.3%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$18.89-11.2%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$3.96B+61.3%
Enterprise value$3.93B+63.5%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0.0×
Current ratio22.6×+1.6×

Where this comes from

Calculated from Edgewise Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s book value per share?
Edgewise Therapeutics, Inc. (EWTX) reported book value per share of $4.60 in Q1 2026.
How has Edgewise Therapeutics, Inc.'s book value per share changed year-over-year?
Edgewise Therapeutics, Inc.'s book value per share increased by 1.9% year-over-year, from $4.52 to $4.60.
What is the long-term trend for Edgewise Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s book value per share has grown at a -35.4% compound annual growth rate (CAGR), from -$45.22 to $5.07.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.